Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX

被引：16
|
作者：
Barnes, C. [1 ]
Davis, A. [1 ]
Furmedge, J. [1 ]
Egan, B. [2 ]
Donnan, L. [3 ]
Monagle, P. [1 ]
机构：
[1] Royal Childrens Hosp, Henry Ekert Haemophilia Treatment Ctr, Melbourne, Vic 3052, Australia
[2] Royal Childrens Hosp, Dept Physiotherapy, Melbourne, Vic 3052, Australia
[3] Royal Childrens Hosp, Dept Orthoped, Melbourne, Vic 3052, Australia
来源：
HAEMOPHILIA | 2010年 / 16卷 / 05期
关键词：
D O I：
10.1111/j.1365-2516.2007.01446.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：840 / 841
页数：2
相关论文
共 50 条
  • [41] Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units
    Ter Avest, P. C.
    Fischer, K.
    Gouw, S. C.
    Van Dijk, K.
    Mauser-Bunschoten, E. P.
    HAEMOPHILIA, 2010, 16 : 71 - 79
  • [42] Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia
    Mathias, M
    Khair, K
    Hann, I
    Liesner, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (03) : 366 - 368
  • [43] Treatment of Haemophilia a (HA) Patients with Inhibitors: Immune Tolerance Induction with a Single Factor VIII/Von Willebrand Factor Concentrate in an Observational Immune Tolerance Induction Study (ObsITI)
    Ettingshausen, C. Escuriola
    Berntorp, Erik
    Dargaud, Yesim
    Gutowski, Zeynep
    Negrier, Claude
    Pavlova, Anna
    Oldenburg, Johannes
    BLOOD, 2018, 132
  • [44] Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
    Reipert, Birgit M.
    van den Helden, Patiline M. W.
    Schwarz, Hans-Peter
    Hausl, Christina
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 12 - 25
  • [45] USE OF RITUXIMAB IN HEMOPHILIA B PATIENTS WITH ANAPHYLAXIS AND FACTOR IX INHIBITOR.
    Kiehm, J.
    Qamar, N.
    Acharya, S.
    Kaplan, B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A78 - A78
  • [46] Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B
    Abajas, Yasmina L.
    Monahan, Paul Edward
    Nielsen, Brenda
    Petrini, Pia
    Ranta, Susanna
    Allen, Geoffrey A.
    Horneff, Silvia
    Martensson, Annika
    Oldenburg, Johannes
    Ljung, Rolf
    BLOOD, 2018, 132
  • [47] Factors influencing the outcome of immune tolerance induction in patients with haemophilia A and inhibitors
    Marquardt, N.
    Bailer, B.
    Goldmann, G.
    Horneff, S.
    Pavlova, A.
    Brackmann, H-H
    Oldenburg, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 587 - 587
  • [48] Successful induction of immune tolerance in a patient with haemophilia B with inhibitor
    Suzuki, N
    Watanabe, J
    Kudoh, T
    Hori, T
    Hatakeyama, N
    Mizue, N
    Oda, T
    Tsutsumi, H
    HAEMOPHILIA, 2003, 9 (03) : 340 - 342
  • [49] Nonacog-αFactor IX inhibitor development and anaphylaxis in a child with factor IX deficiency treated with rituximab and desensitisation: case report
    Reactions Weekly, 2008, 1191 (1) : 19 - 19
  • [50] The B-Natural study-The outcome of immune tolerance induction therapy in patients with severe haemophilia B
    Astermark, Jan
    Holstein, Katharina
    Abajas, Yasmina L.
    Kearney, Susan
    Croteau, Stacy E.
    Liesner, Riana
    Funding, Eva
    Kempton, Christine L.
    Acharya, Suchitra
    Lethagen, Stefan
    LeBeau, Petra
    Bowen, Joel
    Berntorp, Erik
    Shapiro, Amy D.
    HAEMOPHILIA, 2021, 27 (05) : 802 - 813
12345